Flexray Medical ApS: Financial statements 2022
CVR: 36890509
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
Flexray Medical ApS (CVR 36890509) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 5,481,224 and a net result of DKK 2,416,705 compared with DKK 2,660,641 the year before. That is a decrease of 1% compared with the year before. Equity in the 2022 report amounted to DKK 6,765,944. The solvency ratio was 81.3%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 5,481,224
- Profit/Loss
- DKK 2,416,705
- Equity
- DKK 6,765,944
- Total Assets
- DKK 8,318,351
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 5.5 mio. | 2.4 mio. | 6.8 mio. | 3 |
| 2021 | - | 5.5 mio. | 2.7 mio. | 5.1 mio. | 3 |
| 2020 | - | 1.6 mio. | 78 t. | 3.9 mio. | 3 |
| 2019 | - | 3.9 mio. | 1.6 mio. | 4.2 mio. | 3 |
| 2018 | - | 2.6 mio. | 727 t. | 2.6 mio. | 3 |
Official annual report
Keep an eye on Flexray Medical ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of June 9, 2022, Simon Dyrup Nielsen is registered as director of Flexray Medical ApS.
About Flexray Medical ApS
Flexray Medical ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2015. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Mads Vittrup and Simon Dyrup Nielsen. The company is owned by Simba Holding ApS and SDHD Holding ApS. The company has 5 employees (2026). In 2026, the company reported a gross profit of DKK 2,930,775 and a net result of DKK 733,340 compared with DKK 2,437,076 the year before. Equity in the 2026 report amounted to DKK 10,144,844.